Next-Generation Androgen Receptor-Signaling Inhibitors for Prostate Cancer: Considerations for Older Patients
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Geriatrics and Gerontology
Link
http://link.springer.com/content/pdf/10.1007/s40266-020-00809-3.pdf
Reference87 articles.
1. Prostate Cancer: Statistics 2020. Cancer. https://www.cancer.net/cancer-types/prostate-cancer/statistics. Accessed 22 Apr 2020.
2. Boyle HJ, Alibhai S, Decoster L, Efstathiou E, Fizazi K, Mottet N, et al. Updated recommendations of the International Society of Geriatric Oncology on prostate cancer management in older patients. Eur J Cancer. 2019;116:116–36.
3. Lichtman SM, Wildiers H, Launay-Vacher V, Steer C, Chatelut E, Aapro M. International Society of Geriatric Oncology (SIOG) recommendations for the adjustment of dosing in elderly cancer patients with renal insufficiency. Eur J Cancer. 2007;43(1):14–34.
4. Graff JN, Smith MR, Saad F, et al. Age-related efficacy and safety of apalutamide (APA) plus ongoing androgen deprivation therapy (ADT) in subgroups of patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC): post hoc analysis of SPARTAN (abstract). J Clin Oncol. 2019;37(15_suppl):5024. https://doi.org/10.1200/JCO.2019.37.15_suppl.5024.
5. Loh KP, Mohile SG, Kessler E, Fung C. Treatment of metastatic prostate cancer in older adults. Curr Oncol Rep. 2016;18(10):63.
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Real-World Treatment Patterns Among French Patients With Metastatic Castration-Resistant Prostate Cancer Under Abiraterone or Enzalutamide;Clinical Genitourinary Cancer;2023-10
2. Metastatic Hormone-Sensitive Prostate Cancer: Toward an Era of Adaptive and Personalized Treatment;American Society of Clinical Oncology Educational Book;2023-06
3. Marine Natural Products with Activities against Prostate Cancer: Recent Discoveries;International Journal of Molecular Sciences;2023-01-11
4. Association between age and efficacy of combination systemic therapies in patients with metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysis;Prostate Cancer and Prostatic Diseases;2022-10-25
5. Prostate Cancer Biomarkers: From diagnosis to prognosis and precision-guided therapeutics;Pharmacology & Therapeutics;2021-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3